• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

AmSurg Corp.

NASDAQ:AMSG

$27.47 -$0.30 (-1.08%)

REAL-TIME: Last trade at

BofA/Merrill's healthcare analyst research team holds a conference call

Barclays' medical supplies and devices analysts hold a conference call

AmSurg Remains Neutral

AmSurg Remains Neutral - Analyst Blog

A Forward Look, The Year Ahead - Featured Research on Amsurg Corp and Community Health Systems

AmSurg Corp. to Present at the Deutsche Bank Securities, Inc. 37th Annual Health Care Conference

AmSurg Corp. to Present at the Deutsche Bank Securities, Inc. 37th Annual Health Care Conference

AmSurg Continues to Track Double-Digit Growth

AmSurg Beats, Guides Higher - Analyst Blog

AmSurg Beats, Guides Higher

AmSurg's earnings up 35 percent in 1Q

Amsurg Corp (AMSG) Tops Q1 EPS by 2c; Boosts FY12 Outlook, Guides Q2 EPS

AmSurg sees Q2 EPS 49c-51c, consensus 49c

AmSurg raises 2012 EPS outlook to $1.97-$2.01 from $1.95-$1.99

AmSurg cites stronger than expected Q1 results for raised outlook

AmSurg reports Q1 EPS 50c, consensus 48c

AmSurg Reports 35% Growth in First-Quarter Net Earnings Per Diluted Share to $0.50

AmSurg removed from the short-term buy list at Deutsche Bank

Piper Jaffray's medtech research team holds a conference call

Barclays to host a field trip

AmSurg Corp. to Broadcast 2012 First Quarter Conference Call Live on the Internet

BofA/Merrill's analysts discuss Supreme Court oral arguments on conference call

AmSurg Reiterated at Neutral - Analyst Blog

AmSurg Reiterated at Neutral

Cantor Fitzgerald Starts AmSurg (AMSG) at Hold; Growth Slowed, Outlook Remains Uncertain

AmSurg Corp. to Present at the Barclays Capital 2012 Global Healthcare Conference

AmSurg: An Undervalued Opportunity

AmSurg Beats, Margin Down - Analyst Blog

AmSurg Beats, Margin Down

AmSurg produced strong revenue growth for the Q4

Despite Weak Same-Facility Revenue Growth, Amsurg Sees Improvements in 2012

Earnings: AmSurg 4Q profit up 24%

Jefferies Raises Numbers on AmSurg (AMSG) After Q4, Says Growth Accelerates

AmSurg sees Q1 EPS 47c-49c, consensus 46c

AmSurg sees FY12 revenue $900M-$920M, consensus $889.78M

AmSurg sees FY12 EPS $1.95-$1.99, consensus $1.96

AmSurg reports Q4 EPS 43c, consensus 46c

AmSurg Reports Fourth-Quarter Net Earnings Per Diluted Share from Continuing Operations of $0.44 Including NSC Transaction Costs of $0.02

AmSurg Corp. to Present at the Citi 2012 Global Health Care Conference

AmSurg Corp. to Present at the Citi 2012 Global Health Care Conference

See More Articles...